ArticleJournal of cellular and molecular medicine2020

miR-152-5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7.

Shiqi Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.